Breaking News Instant updates and real-time market news.

SCPH

scPharmaceuticals

$4.94

-0.43 (-8.01%)

20:25
08/20/18
08/20
20:25
08/20/18
20:25

scPharmaceuticals' Furoscix ultimately to reach the market, says BMO Capital

BMO Capital analyst Gary Nachman kept his Outperform rating and $14 price target on scPharmaceuticals after its Q2 results, saying the investors' focus remains on the company working through the FDA complete response letter for its Furoscix drug. The analyst notes that the management intends to address the issues raised by the FDA with its September 24th update, adding that after a 1-2 year delay, he still expects the drug to reach the market.

  • 24

    Sep

SCPH scPharmaceuticals
$4.94

-0.43 (-8.01%)

06/01/18
JEFF
06/01/18
NO CHANGE
Target $26
JEFF
Buy
scPharmaceuticals likely to receive CRL for Furoscix, says Jefferies
After the FDA found deficiencies in Furoscix's new drug application filing, Jefferies analyst David Steinberg sees increased likelihood that the company receives a complete response letter by the June 23 action date. This is likely to have a minimal financial Impact for this year, Steinberg tells investors in a research note. His model assumes a Q4 Furoscix launch, with "very modest" contributions from scPharmaceuticals' heart failure product candidate this year. The analyst keeps a Buy rating on scPharmaceuticals with a $26 price target.
06/13/18
BMOC
06/13/18
NO CHANGE
Target $14
BMOC
Outperform
scPharmaceuticals' Furoscix 'still alive' despite CRL, says BMO Capital
BMO Capital analyst Gary Nachman said scPharmaceuticals' announcement of a Complete Response Letter, or CRL, from the FDA regarding its application for Furoscix was "disappointing but expected." Nachman, who still believes there will be an ultimate path forward for Furoscix, is now assuming a one to two year delay and is lowering his estimates. He maintains an Outperform rating on the stock, but lowered his price target for scPharmaceuticals shares to $14 from $24.
06/14/18
JEFF
06/14/18
NO CHANGE
Target $12
JEFF
Buy
scPharmaceuticals price target lowered to $12 from $26 at Jefferies
Jefferies analyst David Steinberg lowered his price target for scPharmaceuticals to $12 after the company received a Complete Response Letter for its heart failure product candidate Furosci. The letter, which indicated the need for additional human factor studies, device modifications, and a possible clinical validation study, is "arguably more onerous than previously expected," Steinberg tells investors in a research note. The analyst, however, continues to view Furoscix as approvable and keeps a Buy rating on scPharmaceuticals.
06/14/18
LEER
06/14/18
NO CHANGE
Target $12
LEER
Outperform
scPharmaceuticals price target lowered to $12 from $20 at Leerink
Leerink analyst Ami Fadia lowered her price target for scPharmaceuticals to $12 from $20 after the company announced that it received a Complete Response Letter from the FDA on Furoscix. The analyst believes that making changes to the design of the device - should the FDA ultimately require it - is no small task and a resubmission involving this will likely take longer than her previous 6-12 month delay estimate to fully complete. In light of this uncertainty, Fadia pushes out approval of Furoscix by 2 years to mid-2020. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

BB

BlackBerry

$8.05

-0.26 (-3.13%)

13:45
05/23/19
05/23
13:45
05/23/19
13:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
05/23/19
05/23
13:45
05/23/19
13:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

FL

Foot Locker

$52.92

-1.28 (-2.36%)

13:38
05/23/19
05/23
13:38
05/23/19
13:38
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

INTU

Intuit

$241.74

-5.78 (-2.34%)

, ADSK

Autodesk

$167.63

-6.48 (-3.72%)

13:38
05/23/19
05/23
13:38
05/23/19
13:38
Earnings
Notable companies reporting after market close »

Notable companies…

INTU

Intuit

$241.74

-5.78 (-2.34%)

ADSK

Autodesk

$167.63

-6.48 (-3.72%)

ROST

Ross Stores

$93.98

-0.62 (-0.66%)

HPQ

HP Inc.

$19.12

-0.17 (-0.88%)

SPLK

Splunk

$129.20

-6.6 (-4.86%)

HPE

HP Enterprise

$14.31

-0.23 (-1.58%)

DXC

DXC Technology

$52.22

-2.28 (-4.18%)

DECK

Deckers Brands

$149.16

-1.05 (-0.70%)

LGF.A

Lionsgate

$15.83

-0.19 (-1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 29

    May

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 12

    Jun

  • 13

    Jun

  • 09

    Jul

AXP

American Express

$118.06

-1.96 (-1.63%)

13:35
05/23/19
05/23
13:35
05/23/19
13:35
Options
American Express put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 13

    Nov

KTOS

Kratos Defense

$20.70

0.28 (1.37%)

13:25
05/23/19
05/23
13:25
05/23/19
13:25
Options
Kratos Defense call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
05/23/19
05/23
13:25
05/23/19
13:25
General news
Treasury's $11 B 10-year TIPS sale was surprisingly solid »

Treasury's $11 B…

ACAD

Acadia

$24.82

-0.29 (-1.15%)

, ALKS

Alkermes

$24.22

-0.83 (-3.31%)

13:25
05/23/19
05/23
13:25
05/23/19
13:25
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

ACAD

Acadia

$24.82

-0.29 (-1.15%)

ALKS

Alkermes

$24.22

-0.83 (-3.31%)

ITCI

Intra-Cellular

$13.34

0.26 (1.99%)

NBIX

Neurocrine

$78.45

-1.42 (-1.78%)

SAGE

Sage Therapeutics

$174.50

-0.5 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

  • 27

    Sep

ICPT

Intercept

$85.25

-0.98 (-1.14%)

, RHHBY

Roche

$0.00

(0.00%)

13:21
05/23/19
05/23
13:21
05/23/19
13:21
Recommendations
Intercept, Roche analyst commentary at RBC Capital »

RBC sees…

ICPT

Intercept

$85.25

-0.98 (-1.14%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

  • 03

    Jun

  • 20

    Jun

  • 20

    Jun

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
05/23/19
05/23
13:17
05/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
05/23/19
05/23
13:16
05/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$13.72

-0.335 (-2.38%)

13:15
05/23/19
05/23
13:15
05/23/19
13:15
Options
Tencent put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,135.50

-17.61 (-1.53%)

, GOOG

Alphabet

$1,130.85

-19.65 (-1.71%)

13:13
05/23/19
05/23
13:13
05/23/19
13:13
Hot Stocks
Google announces integration with food delivery service providers »

In a post to a corporate…

GOOGL

Alphabet Class A

$1,135.50

-17.61 (-1.53%)

GOOG

Alphabet

$1,130.85

-19.65 (-1.71%)

UBER

Uber

$40.51

-0.58 (-1.41%)

GRUB

GrubHub

$65.02

-3.52 (-5.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 19

    Jun

  • 19

    Jun

  • 27

    Jun

  • 27

    Oct

VRNT

Verint

$56.01

-5.2 (-8.50%)

13:11
05/23/19
05/23
13:11
05/23/19
13:11
Hot Stocks
Verint says short seller report 'inaccurate and deliberately misleading' »

Verint Systems issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 20

    Jun

13:08
05/23/19
05/23
13:08
05/23/19
13:08
General news
10-Yr TIPS Auction Coupon Rate data reported »

10-Yr TIPS Auction Coupon…

13:08
05/23/19
05/23
13:08
05/23/19
13:08
General news
10-Yr TIPS Auction Total Amount data reported »

10-Yr TIPS Auction Total…

M

Macy's

$21.36

-0.45 (-2.06%)

13:05
05/23/19
05/23
13:05
05/23/19
13:05
Options
Macy's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEBK

Wellesley Bancorp

$35.05

(0.00%)

13:02
05/23/19
05/23
13:02
05/23/19
13:02
Hot Stocks
Wellesley Bancorp raises quarterly cash dividend 9.1% to 6c per share »

Wellesley Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JYNT

Joint Corp.

$16.00

-1.5 (-8.57%)

13:02
05/23/19
05/23
13:02
05/23/19
13:02
Recommendations
Joint Corp. analyst commentary at DA Davidson »

Joint Corp. weakness on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

AMZN

Amazon.com

$1,812.11

-45.63 (-2.46%)

12:57
05/23/19
05/23
12:57
05/23/19
12:57
Periodicals
Amazon developing wrist device that can read human emotions, Bloomberg says »

Amazon is working on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 25

    Jun

JYNT

Joint Corp.

$16.00

-1.5 (-8.57%)

12:56
05/23/19
05/23
12:56
05/23/19
12:56
Periodicals
Joint Corp. mentioned cautiously by Seeking Alpha contributor »

In a short report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

ESV

Ensco Rowan

$8.98

-0.87 (-8.83%)

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Options
Ensco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Conference/Events
Federal Reserve Bank of Dallas to hold a conference »

Atlanta Federal Reserve…

12:55
05/23/19
05/23
12:55
05/23/19
12:55
Conference/Events
JPMorgan biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Fye,…

INTU

Intuit

$241.77

-5.75 (-2.32%)

12:50
05/23/19
05/23
12:50
05/23/19
12:50
Hot Stocks
Senators ask Intuit about reports of misleading taxpayers on free options »

Senator Elizabeth Warren…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.